Drug resistance is still the major threat to global tuberculosis (TB) control, and drug-resistant
(DR) Mycobacterium tuberculosis (M. tuberculosis) strains have become the main challenge …

ABSTRACT Introduction Pharmacological treatment of Buruli ulcer (Mycobacterium ulcerans
infection; BU) is highly effective, as shown in two randomized trials in Africa. Areas covered …

Background Leprosy control is based on early diagnosis and multidrug therapy. For
treatment purposes, leprosy patients can be classified as paucibacillary (PB) or …

The ongoing transmission of Mycobacterium (M.) leprae reflected in a very slow decline in
leprosy incidence, forces us to be innovative and conduct cutting-edge research. Single …

Leprosy still poses major therapeutic challenges. We have effective antibiotics to cure the
infection, but the immune mediated peripheral nerve damage can continue long after …

In recent years, clofazimine (CFZ) has been regaining prominence for the treatment of
tuberculosis. However, it shows limited efficacy as a single drug and optimal combination …

In the last decade many leprologists around the world have been advocating the
development and testing of new antimicrobial treatments for leprosy but limited new clinical …

Introduction: Leprosy is a chronic infectious disease caused by the intracellular parasite
Mycobacterium leprae. The diagnosis is essentially clinical, based on symptoms, skin exam …

Leprosy was supposed to be eliminated by WHO at the global level by the end of the year
2000; however, it still remains a significant public health problem at a national level in six …

Objectives: To estimate the prevalence of Leprosy in Azerbaijan, Iran. Methods: A total of
195 new leprosy cases referred to and registered in Bababaghi Center, Azerbaijan …